These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 28894087)
1. Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma. Chiu DK; Tse AP; Xu IM; Di Cui J; Lai RK; Li LL; Koh HY; Tsang FH; Wei LL; Wong CM; Ng IO; Wong CC Nat Commun; 2017 Sep; 8(1):517. PubMed ID: 28894087 [TBL] [Abstract][Full Text] [Related]
2. Tumor derived exosomal ENTPD2 impair CD8 Shi M; Ye L; Zhao L; He L; Chen J; Zhang J; Su Y; Dong H; Liu J; Liang L; Zheng W; Xiao Y; Liu H; Yang X; Yang Z Cell Commun Signal; 2024 May; 22(1):274. PubMed ID: 38755598 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid-derived suppressor cells in hepatocellular carcinoma. Liu Y; Chen X; Luo W; Zhao Y; Nashan B; Huang L; Yuan X Cancer Med; 2023 Aug; 12(15):16370-16385. PubMed ID: 37326143 [TBL] [Abstract][Full Text] [Related]
4. PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma. Liu X; Liu M; Wu H; Tang W; Yang W; Chan TTH; Zhang L; Chen S; Xiong Z; Liang J; Wai-Yiu Si-Tou W; Shu T; Li J; Cao J; Zhong C; Sun H; Kwong TT; Leung HHW; Wong J; Bo-San Lai P; To KF; Xiang T; Jao-Yiu Sung J; Chan SL; Zhou J; Sze-Lok Cheng A JHEP Rep; 2024 Jul; 6(7):101087. PubMed ID: 38882672 [TBL] [Abstract][Full Text] [Related]
5. Radiation Therapy and Myeloid-Derived Suppressor Cells: Breaking Down Their Cancerous Partnership. Bergerud KMB; Berkseth M; Pardoll DM; Ganguly S; Kleinberg LR; Lawrence J; Odde DJ; Largaespada DA; Terezakis SA; Sloan L Int J Radiat Oncol Biol Phys; 2024 May; 119(1):42-55. PubMed ID: 38042450 [TBL] [Abstract][Full Text] [Related]
6. IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment. Mei Y; Zhu Y; Yong KSM; Hanafi ZB; Gong H; Liu Y; Teo HY; Hussain M; Song Y; Chen Q; Liu H Cell Rep; 2024 Mar; 43(3):113835. PubMed ID: 38412100 [TBL] [Abstract][Full Text] [Related]
7. Size-Tunable Nanoregulator-Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma. Tang Y; Shu Z; Zhu M; Li S; Ling Y; Fu Y; Hu Z; Wang J; Yang Z; Liao J; Xu L; Yu M; Peng Z Adv Healthc Mater; 2023 Dec; 12(30):e2302013. PubMed ID: 37665720 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration. Liu A; Gammon ST; Pisaneschi F; Boda A; Ager CR; Piwnica-Worms D; Hong DS; Curran MA JCI Insight; 2024 Jan; 9(1):. PubMed ID: 37988164 [TBL] [Abstract][Full Text] [Related]
9. Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells. Clavijo PE; Moore EC; Chen J; Davis RJ; Friedman J; Kim Y; Van Waes C; Chen Z; Allen CT Oncotarget; 2017 Aug; 8(34):55804-55820. PubMed ID: 28915554 [TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells coming of age. Veglia F; Perego M; Gabrilovich D Nat Immunol; 2018 Feb; 19(2):108-119. PubMed ID: 29348500 [TBL] [Abstract][Full Text] [Related]
14. Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination. Heine A; Flores C; Gevensleben H; Diehl L; Heikenwalder M; Ringelhan M; Janssen KP; Nitsche U; Garbi N; Brossart P; Knolle PA; Kurts C; Höchst B Oncoimmunology; 2017; 6(8):e1338995. PubMed ID: 28920004 [TBL] [Abstract][Full Text] [Related]
15. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway. Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054 [TBL] [Abstract][Full Text] [Related]
16. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy. Zhou J; Liu M; Sun H; Feng Y; Xu L; Chan AWH; Tong JH; Wong J; Chong CCN; Lai PBS; Wang HK; Tsang SW; Goodwin T; Liu R; Huang L; Chen Z; Sung JJ; Chow KL; To KF; Cheng AS Gut; 2018 May; 67(5):931-944. PubMed ID: 28939663 [TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cell and macrophage exert distinct angiogenic and immunosuppressive effects in breast cancer. Fang Z; Wen C; Chen X; Yin R; Zhang C; Wang X; Huang Y Oncotarget; 2017 Aug; 8(33):54173-54186. PubMed ID: 28903332 [TBL] [Abstract][Full Text] [Related]
19. Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers. Ishibashi M; Yamaguchi H; Hirotani Y; Sakurada A; Endo T; Sugitani M; Takayama T; Makishima M; Esumi M Arch Virol; 2018 Apr; 163(4):855-865. PubMed ID: 29248968 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review. Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]